[Drug therapy for headache: (author's transl)].
The absence of essentially new principles among the substances which have recently made their appearance on the market for the treatment of headache is conspicuous. We have learned, however, to take a holistic view of the complex problem of headache and to combine medication with all other therapeutic measures in a logical way and also to use medicines for their relevant indications and to use them together. We have been able to handle even "problem cases" with a history of many different therapeutic attempts. The rate of satisfactory therapeutic success over a longer time amounted to two thirds of these cases.
D000700:Analgesics / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003000:Clonidine / Q000008:administration & dosage; D004087:Dihydroergotamine / Q000008:administration & dosage; D004878:Ergotamine / Q000008:administration & dosage; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009437:Neuralgia / Q000188:drug therapy; D010918:Pizotyline / Q000008:administration & dosage; D012890:Sleep; D019966:Substance-Related Disorders / Q000517:prevention & control; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D010918:Pizotyline; D004087:Dihydroergotamine; D003000:Clonidine; D004878:Ergotamine
Medikamentöse Kopfschmerztherapie